Bumper Offer - Urjas oil Just @ Rs. 1
Olmesar A 40 Tablet (15) is a prescription medicine that is available as a Tablet. The alternative uses of Olmesar A 40 Tablet (15) have also been explained below.
The right dosage of Olmesar A 40 Tablet (15) depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Olmesar A 40 Tablet (15) include Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmesar A 40 Tablet (15) as well, which are listed below. Such side effects of Olmesar A 40 Tablet (15) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Olmesar A 40 Tablet (15) is Severe for pregnant women and Mild for women who are breastfeeding. Warnings related to Olmesar A 40 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Olmesar A 40 Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease are examples of such conditions. Some other conditions that can be affected by Olmesar A 40 Tablet (15) are listed in the contraindications section below.
Drug interactions for Olmesar A 40 Tablet (15) have been reported in the medical literature. See below for a complete list.
You should also be aware that Olmesar A 40 Tablet (15) is not safe while driving, and is not addiction.
Olmesar A 40 Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olmesar A 40 Tablet (15) is used -
Moderate
Mild
Is the use of Olmesar A 40 Tablet (15) safe for pregnant women?
Olmesar A should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olmesar A 40 Tablet (15) safe during breastfeeding?
Olmesar A may have very limited harmful effects for breastfeeding women.
What is the effect of Olmesar A 40 Tablet (15) on the Kidneys?
Olmesar A rarely affects the kidneys.
What is the effect of Olmesar A 40 Tablet (15) on the Liver?
Side effects of Olmesar A rarely affect the liver.
What is the effect of Olmesar A 40 Tablet (15) on the Heart?
Olmesar A is rarely harmful for the heart.
Olmesar A 40 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmesar A 40 Tablet (15) unless your doctor advises you to do so -
Is this Olmesar A 40 Tablet (15) habit forming or addictive?
Forming a habit of Olmesar A 40 Tablet (15) has not been reported.
Interaction between Food and Olmesar A 40 Tablet (15)
Taking Olmesar A 40 Tablet (15) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmesar A 40 Tablet (15)
Consumption of alcohol and Olmesar A 40 Tablet (15) together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
